Fulgent Genetics Lowers FY2026 Adj EPS Guidance from $(1.45) to $(1.59) vs $(0.68) Est; Affirms FY2026 Sales Guidance of $350.000M vs $349.465M Est

Benzinga Newsdesk www.benzinga.com Negative 95.3%